๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug treatment in dementia

โœ Scribed by Roger Bullock

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
30 KB
Volume
16
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug treatment of dementia
Drug treatment of dementia
โœ H. Coper ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 70 KB
Anti-dementia drugs
Anti-dementia drugs
โœ Harry Allen ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 76 KB ๐Ÿ‘ 2 views

## New Drugs for Dementia The introduction of new drugs for dementia has posed a number of problems for clinicians and prescribers with regard to their ecacy and how best they should be introduced into practice. The ยฎrst ยฎve contributions of this issue bring together a number of dierent perspective

Drug therapy of frontotemporal dementia
Drug therapy of frontotemporal dementia
โœ Hervรฉ Allain; Daniรจle Bentuรฉ-Ferrer; Olivier Tribut; Marc Mรฉrienne; Serge Bellia ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB

## Abstract Frontal lobe dementia, or more generally frontotemporal dementia (FTD), includes several clinical entities and, although highly prevalent, lacks any codified therapeutic strategy. The present review is an attempt to depict the main neurochemical correlates of FTD and, as a consequence,

Neuroleptics in the treatment of dementi
Neuroleptics in the treatment of dementia
โœ Dr. Trey Sunderland; Michael A. Silver ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 659 KB

The authors review the history of neuroleptic treatment in dementia. The initial review of 34 studies published since 1954 was limited to the 20 double-blind and/or placebo-controlled studies. Sixty per cent of the studies revealed generally positive clinical results in demented patients following n